$DXBRF - Key Growth Initiatives for 2019
The Company is pursuing a number of initiatives that are expected to result in significant revenue growth in 2019 and in future years. Key objectives for this year include the following:
Continue to expand the number of dispensaries selling the Dixie Brands portfolio of THC-infused products within the existing U.S. footprint of California, Colorado, Maryland, Michigan and Nevada. California is estimated at one-third of the total U.S. cannabis market and represents a significant growth opportunity for Dixie which re-launched in the state in the final months of 2018.Establish operations in four-to-six new U.S. states in 2019, of which Michigan is the first.Secure additional distribution agreements for Aceso Hemp and Therabis to grow the presence of both brands in bricks and mortar locations and complement their established e-commerce channels.Continue to innovate by introducing new products that take advantage of Dixie's intellectual property and expertise.Enter the Canadian cannabis-infused products market by the end of 2019, following the publication of final regulations by Health Canada, through a licensing agreement with Auxly Cannabis.Evaluate potential mergers and acquisitions in order to accelerate growth, enter new markets and add new brands.
Mr. Smith added: "We expect to generate growth across all areas of our business in 2019 as the market for cannabis-infused products continues to increase and we take advantage of our leadership position in the space. Key drivers will include our full roll-out across California, our entry into additional U.S. states, and expanded distribution of our CBD brands Aceso Hemp and Therabis. Over the longer term, we anticipate realizing further growth from our Latin American joint venture partnership with Khiron Life Sciences, other international opportunities, and the ongoing cannabis legalization trend in the United States."
